Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Gallbladder cancer mostly occurs in middle-aged and elderly people over 60 years old, with a slightly higher incidence in women than men. It is a biliary malignancy with insidious onset and early metastasis. Treatment plans are determined comprehensively based on stage, lesion size, and metastasis. If detected early and treated in a standardized manner, patient survival prognosis can be significantly improved. Conversely, missing the optimal intervention period often leads to rapid disease progression, limited treatment options, and significantly reduced quality of life.
Immune reconstruction cell therapy is a recent breakthrough in gallbladder cancer treatment. This therapy repairs the patient’s immune system, enhancing the body’s ability to recognize and eliminate cancer cells, thereby delaying disease progression, reducing recurrence risk, and improving resistance to drug tolerance. It is suitable for postoperative consolidation therapy, late-stage control, and patients unable to tolerate conventional treatments.
① This therapy can be combined with other traditional treatment methods to reduce side effects.
② Suitable for postoperative consolidation to reduce metastasis risk.
③ Can be chosen as the main treatment method for some patients who cannot undergo surgery or tolerate radiotherapy and chemotherapy.
④ At United Life International Medical Center, this therapy has been integrated into multidisciplinary comprehensive treatment plans, bringing clinical benefits to many patients.
In actual treatment, cancer patients undergoing surgery, radiotherapy, or chemotherapy often face impaired immune function, increased infection risk, and slow recovery. To better support patients during treatment, improve tolerance, and enhance survival quality, it is necessary to scientifically design phased immune reconstruction plans tailored to different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effectiveness of anti-tumor treatment.
● Mid-term plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term plan: Improve overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and prolonging survival.
1. Surgical Treatment: First Choice for Early Stage
Surgery remains the only potentially curative option for gallbladder cancer. If the tumor is confined to the gallbladder, radical cholecystectomy can be performed. For advanced stages, partial hepatectomy, bile duct resection, or lymph node dissection may be required. Due to the high risk of recurrence after surgery, consolidation with other therapies is often necessary.
2. Chemotherapy: Adjunct and Disease Control
For advanced or high-risk postoperative patients, chemotherapy can delay tumor progression and improve quality of life. Gemcitabine combined with cisplatin is a common first-line regimen, suitable for middle to late-stage patients or those unable to undergo surgery. However, chemotherapy often comes with side effects such as nausea and immunosuppression, requiring individualized management.
3. Radiotherapy: Local Control and Symptom Relief
Radiotherapy is suitable for patients with localized lesions or positive surgical margins, effectively controlling local recurrence. It is also used to relieve pain or compression symptoms caused by metastasis. Modern image-guided radiotherapy techniques make it more precise and reduce damage to surrounding tissues.
4. Targeted Therapy: Searching for Specific Targets
Some gallbladder cancer patients have gene abnormalities such as HER2 and VEGFR. Targeted drugs against these mutations can partially inhibit tumor progression. For example, trastuzumab has shown potential in some HER2-positive cases. Gene testing is required to guide treatment.
5. Minimally Invasive Interventional Therapy: Local Control and Adjunct Option
For some patients with locally advanced, unresectable disease, minimally invasive techniques such as transarterial chemoembolization (TACE), radiofrequency ablation, and cryoablation can be attempted. These methods can locally suppress tumor growth, relieve biliary obstruction, and buy time for subsequent treatments.
6. Traditional Chinese Medicine (TCM) as Adjunct: Enhancing Constitution and Improving Symptoms
TCM is mainly used as a supportive method in gallbladder cancer treatment, helping regulate the spleen and stomach, improve appetite, and reduce side effects. Some preparations, such as matrine and tonifying herbal medicines, may relieve symptoms and improve quality of life.
Gallbladder cancer treatment should be tailored to disease stage and individual conditions. Experts at United Life International Medical Center point out that multimodal treatment combined with immune reconstruction cell therapy is offering hope to more patients, particularly in delaying recurrence and improving quality of life. Advocating individualized and precision treatment is the core direction of future gallbladder cancer management.
